WallStreetZenWallStreetZen

NYSE: HAE
Haemonetics Corp Stock Ownership - Who owns Haemonetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Haemonetics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark W. KrollDirector2025-11-101,400$70.56
$98.78kBuy
Roy GalvinEVP Chief Commercial Officer2025-10-31145$50.01
$7.25kSell
Laurie A. MillerSVP Human Resources2025-09-17238$49.95
$11.89kSell
Christopher SimonPresident CEO2025-05-3026,234$69.38
$1.82MSell
Michelle L. BasilEVP and General Counsel2025-05-307,469$69.38
$518.20kSell
James DareccaEVP Chief Financial Officer2025-05-305,864$69.38
$406.84kSell
Laurie A. MillerSVP Human Resources2025-05-302,283$69.38
$158.39kSell
Christopher SimonPresident CEO2025-05-167,089$70.31
$498.43kSell
Laurie A. MillerSVP Human Resources2025-05-16477$70.31
$33.54kSell
Roy GalvinPresident Global Plasma BC2025-05-16257$70.31
$18.07kSell

1 of 2

HAE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HAE insiders and whales buy or sell their stock.

HAE Shareholders

What type of owners hold Haemonetics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.53%5,820,954$347.51MInstitution
Vanguard Group Inc10.25%4,761,135$284.24MInstitution
Neuberger Berman Group LLC8.32%3,865,676$230.78MInstitution
Aqr Capital Management LLC6.81%3,163,104$188.84MInstitution
State Street Corp3.72%1,729,847$103.27MInstitution
Arrowstreet Capital Limited Partnership2.97%1,380,102$82.39MInstitution
Fmr LLC2.86%1,326,902$79.22MInstitution
Citadel Advisors LLC2.77%1,288,432$76.92MInstitution
Holocene Advisors LP2.72%1,264,271$75.48MInstitution
Goldman Sachs Group Inc2.64%1,226,614$73.23MInstitution

1 of 3

HAE vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HAE97.07%2.93%Net Selling
WRBY55.98%44.02%Net SellingNet Selling
LMAT76.86%23.14%Net SellingNet Selling
NNNN0.02%0.00%
XRAY97.40%2.60%Net SellingNet Buying
View Top Medical Stocks

Haemonetics Stock Ownership FAQ

Who owns Haemonetics?

Haemonetics (NYSE: HAE) is owned by 109.49% institutional shareholders, 3.31% Haemonetics insiders, and 0.00% retail investors. Blackrock Inc is the largest individual Haemonetics shareholder, owning 5.82M shares representing 12.53% of the company. Blackrock Inc's Haemonetics shares are currently valued at $349.55M.

If you're new to stock investing, here's how to buy Haemonetics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.